Adam Waldman
Corporate Officer/Principal at TG THERAPEUTICS, INC.
Profile
Adam Waldman is currently the Chief Commercial Officer at TG Therapeutics, Inc. He previously worked at Celgene Corp.
as the Head of Haematology & Oncology Marketing.
Waldman received an undergraduate degree from Rutgers State University of New Jersey and an MBA from the University of Rochester Simon Business School.
Adam Waldman active positions
| Companies | Position | Start |
|---|---|---|
| TG THERAPEUTICS, INC. | Corporate Officer/Principal | 2018-06-03 |
Former positions of Adam Waldman
| Companies | Position | End |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
Training of Adam Waldman
| Rutgers State University of New Jersey | Undergraduate Degree |
| University of Rochester Simon Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Adam Waldman
